DACTINOGET

Dactinomycin or Actinomycin-D, is an intergral part of many chemotherapeutic protocols for Paediatric tumours.

Dactinomycin or Actinomycin-D, is an intergral part of many chemotherapeutic protocols for Paediatric tumours. Its proven efficacy and good tolerability make it a trustworthy anti cancer drug for Paediatric Oncologists.

Indications:

  • As a part of a combination chemotherapy and/or multi-modality treatment regimen, for the treatment of Wilms’ tumor, childhood rhabdomyosarcoma, Ewing’s sarcoma and metastatic, nonseminomatous testicular cancer
  • As a part of a combination chemotherapy regimen, for the treatment of gestational trophoblastic neoplasia
  • As a component of regional perfusion, for the palliative and/or adjunctive treatment of locally recurrent or locoregional solid malignancies

Generic Name

Strength

Standard

Type

Packing

Pack Size

Dactinomycin

0.5 mg

USP

INJ

Vial

 ml